Hainan Yougeng Investment Co., Ltd. agreed to acquire Guangdong Yuanning Pharmaceutical Co.,Ltd. from Honz Pharmaceutical Co., Ltd. for CNY12 million.
October 26, 2023
Share
Hainan Yougeng Investment Co., Ltd. agreed to acquire Guangdong Yuanning Pharmaceutical Co.,Ltd. from Honz Pharmaceutical Co., Ltd. (SZSE:300086) for CNY12 million on October 25, 2023. On October 25, 2023, the 9th session of the company?s 6th directorate approved the proposal on the transfer of 100% stake in Yuanning Pharmaceutical.
HONZ PHARMACEUTICAL CO., LTD., formerly HAINAN HONZ PHARMACEUTICAL CO., LTD., is principally engaged in the research, development, production and distribution of drugs for children. The Company provides western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant and arresting convulsion drugs, as well as nutrition drugs, among others. The Company's products include nimesulide granules, cefminox sodium for injection, Zhike Juhong granules, Ganmao Qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, Jianerle granules, pediatric four vitaminsand calcium gluconate granules, as well as ribavirin pellets and Norfloxacin capsules for adults.
HONZ PHARMACEUTICAL CO., LTD. 
